| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.01 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |